首页> 外国专利> compound, pharmaceutical composition, use of a compound, pyrazine derivative, methods for treatment or prevention, for bone promotion, and for treating bone lesions in cancers

compound, pharmaceutical composition, use of a compound, pyrazine derivative, methods for treatment or prevention, for bone promotion, and for treating bone lesions in cancers

机译:化合物,药物组合物,化合物的用途,吡嗪衍生物,用于治疗或预防,用于骨促进和用于治疗癌症中的骨病变的方法

摘要

"compound, pharmaceutical composition, use of a compound, pyrazine derivative, methods for treating or preventing, promoting bone formation, and for treating bone lesions in cancers" the invention relates to pyrazine derivatives of formula (i) or pharmaceutically acceptable salts thereof; wherein each of n, m and r has any of the meanings defined hereinbelow in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in treating bone disorders or conditions.
机译:“化合物,药物组合物,化合物的用途,吡嗪衍生物,用于治疗或预防,促进骨形成以及用于治疗癌症中骨损伤的方法”,本发明涉及式(i)的吡嗪衍生物或其药学上可接受的盐;其中n,m和r中的每一个具有说明书中下文所定义的任何含义;的制备方法,包含它们的药物组合物及其在制备用于治疗骨疾病或病症的药物中的用途。

著录项

  • 公开/公告号BR112012017884A2

    专利类型

  • 公开/公告日2019-09-24

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号BR20121117884

  • 发明设计人 TAO FENG;

    申请日2011-01-18

  • 分类号C07D401/12;A61K31/397;A61P3/10;A61P25;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号